Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic—A cost-effectiveness analysis

BACKGROUND AND AIM: COVID-19 pandemic burdens the healthcare systems, causes healthcare avoidance, and might worsen the outcomes of inflammatory bowel disease (IBD) management. We aimed to estimate the impact of pandemic-related avoidance on outpatient IBD management, and the cost-effectiveness of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jiaqi, Fekadu, Ginenus, Jiang, Xinchan, You, Joyce H. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989217/
https://www.ncbi.nlm.nih.gov/pubmed/35390064
http://dx.doi.org/10.1371/journal.pone.0266464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989217/
https://www.ncbi.nlm.nih.gov/pubmed/35390064
http://dx.doi.org/10.1371/journal.pone.0266464

Ejemplares similares